The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment.
Read MoreExtensive review of the avantages and limits of currently used clinical scales. Some perspectives are given in the conclusion.
Read MoreAdvantages an limitations of EDSS in multiple sclerosis clinical trials, alternatives an futures directions
Read MoreCompared to traditional clinical trials, virtual or hybrid trials have a number of advantages. We focus on 9 of them in this article. Healint is a pioneer in VCT, our platform is specialised for CNS and immune system disorders.
Read MoreHealint focus is on CNS and inflammatory diseases. In the latter category, Atopic Dermatitis, is a critical health issue with high impact on quality of life. Healint is able to conduct trials in this condition and collect data from patients and/or investigators.
Read MoreHealint and Aptar Digital Health have entered into a collaboration aimed at enhancing the way patients with CNS and immune conditions are managed and treated.
Read MoreDepression has often been linked with Pain. Both CNS conditions can be investigated in fully or hybrid virtual clinical trials. Healint’s platform can run all the clinical scales used to assess drug efficacy.
Read MoreHealint is announcing a collaboration today with the University of Toronto. The objective is to analyze data obtained from Migraine Buddy, in conjunction with data obtained from Environment and Climate Change Canada, in order to understand the impact on air pollution on migraine in Ontario.
Read MoreHealint conducted a study on IBD patients to investigate the best way to administer PRO. Our objective is to make the life of patients easier and improving the quality of clinical trials data.
Read More